Total planned funding: $90,903,823
Allocations
Countries/Regions
| Asia Regional Program | $90,903,823 |
Organizational Types
| NGO | $32,145,612 |
| Own Agency | $25,203,931 |
| University | $10,629,615 |
| Unknown | $7,929,667 |
| Host Country Government Agency | $6,559,278 |
| Multi-lateral Agency | $5,685,608 |
| Private Contractor | $2,460,112 |
| Other USG Agency | $290,000 |
Program Areas
| Treatment | $23,167,029 |
| Governance and Systems | $20,610,830 |
| Management and Operations | $15,024,237 |
| Prevention | $14,906,520 |
| Testing | $10,050,987 |
| Care | $7,144,220 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $22,788,459 |
| HVMS: Management and Operations | $15,024,237 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $12,793,030 |
| OHSS: Health Systems Strengthening | $10,325,008 |
| HVCT: Testing: HIV Testing and Counseling | $10,050,987 |
| HVSI: Strategic Information | $7,346,439 |
| HBHC: Care: Adult Care and Support | $5,263,095 |
| HLAB: Laboratory Infrastructure | $2,939,383 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,762,227 |
| HKID: Care: Orphans and Vulnerable Children | $1,244,726 |
| PDCS: Care: Pediatric Care and Support | $480,554 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $315,488 |
| PDTX: Treatment: Pediatric Treatment | $203,070 |
| HTXD: Treatment: ARV Drugs | $175,500 |
| HVTB: Care: TB/HIV | $155,845 |
| HMBL: Biomedical Prevention: Blood Safety | $35,775 |
Top Partner Programs
U.S. Centers for Disease Control and Prevention:
$18,507,999
Countries/Regions
Asia Regional Program
| 2013 | $7,070,000 |
| 2020 | $11,437,999 |
U.S. Agency for International Development:
$6,595,932
Countries/Regions
Asia Regional Program
| 2013 | $1,015,733 |
| 2020 | $5,580,199 |